RNXT
Income statement / Annual
Last year (2025), RenovoRx Inc's total revenue was $1.12 M,
an increase of 2,511.63% from the previous year.
In 2025, RenovoRx Inc's net income was -$11.17 M.
See RenovoRx Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$1.12 M |
$43.00 K |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$327.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$796.00 K
|
$43.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0.71
|
1
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$6.27 M
|
$6.03 M
|
$5.67 M
|
$4.30 M
|
$3.04 M
|
$2.39 M
|
$3.00 M
|
| General & Administrative Expenses |
$7.04 M
|
$4.99 M
|
$5.73 M
|
$5.65 M
|
$2.63 M
|
$818.00 K
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$7.04 M
|
$4.99 M
|
$5.73 M
|
$5.65 M
|
$2.63 M
|
$818.00 K
|
$899.00 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$13.31 M
|
$11.01 M
|
$11.40 M
|
$9.95 M
|
$5.67 M
|
$3.20 M
|
$3.90 M
|
| Cost And Expenses |
$13.63 M
|
$11.01 M
|
$11.40 M
|
$9.95 M
|
$5.67 M
|
$3.20 M
|
$3.90 M
|
| Interest Income |
$427.00 K
|
$384.00 K
|
$0.00
|
$57.00 K
|
$0.00
|
$3.00 K
|
$63.00 K
|
| Interest Expense |
$0.00
|
$0.00
|
$108.00 K
|
$57.00 K
|
$834.00 K
|
$590.00 K
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$0.00
|
$6.00 K
|
$6.00 K
|
$9.00 K
|
$3.20 M
|
$0.00
|
| EBITDA |
-$12.51 M |
-$10.97 M |
-$11.39 M |
-$9.94 M |
-$5.48 M |
$0.00 |
-$3.84 M |
| EBITDA Ratio |
-11.14
|
-255.12
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-11.14
|
-255.12
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$1.34 M
|
$2.16 M
|
$1.16 M
|
$61.00 K
|
-$653.00 K
|
-$594.00 K
|
$57.00 K
|
| Income Before Tax |
-$11.17 M
|
-$8.81 M
|
-$10.23 M
|
-$9.89 M
|
-$6.32 M
|
-$3.80 M
|
-$3.84 M
|
| Income Before Tax Ratio |
-9.94
|
-204.98
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$11.17 M
|
-$8.81 M
|
-$10.23 M
|
-$9.89 M
|
-$6.32 M
|
-$3.80 M
|
-$3.84 M
|
| Net Income Ratio |
-9.94
|
-204.98
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.32 |
-0.37 |
-0.5 |
-0.54 |
-0.4 |
-0.25 |
-0.22 |
| EPS Diluted |
-0.32 |
-0.37 |
-0.5 |
-0.54 |
-0.4 |
-0.25 |
-0.22 |
| Weighted Average Shares Out |
$35.33 M
|
$23.61 M
|
$20.58 M
|
$18.10 M
|
$17.87 M
|
$17.32 M
|
$17.32 M
|
| Weighted Average Shares Out Diluted |
$35.33 M
|
$23.61 M
|
$20.58 M
|
$18.10 M
|
$17.87 M
|
$17.32 M
|
$17.32 M
|
| Link |
|
|
|
|
|
|
|
